Literature DB >> 15740149

Hydrogen elimination from a hydroxycyclopentadienyl ruthenium(II) hydride: study of hydrogen activation in a ligand-metal bifunctional hydrogenation catalyst.

Charles P Casey1, Jeffrey B Johnson, Steven W Singer, Qiang Cui.   

Abstract

At high temperatures in toluene, [2,5-Ph(2)-3,4-Tol(2)(eta(5)-C(4)COH)]Ru(CO)(2)H (3) undergoes hydrogen elimination in the presence of PPh(3) to produce the ruthenium phosphine complex [2,5-Ph(2)-3,4-Tol(2)-(eta(4)-C(4)CO)]Ru(PPh(3))(CO)(2) (6). In the absence of alcohols, the lack of RuH/OD exchange, a rate law first order in Ru and zero order in phosphine, and kinetic deuterium isotope effects all point to a mechanism involving irreversible formation of a transient dihydrogen ruthenium complex B, loss of H(2) to give unsaturated ruthenium complex A, and trapping by PPh(3) to give 6. DFT calculations showed that a mechanism involving direct transfer of a hydrogen from the CpOH group to form B had too high a barrier to be considered. DFT calculations also indicated that an alcohol or the CpOH group of 3 could provide a low energy pathway for formation of B. PGSE NMR measurements established that 3 is a hydrogen-bonded dimer in toluene, and the first-order kinetics indicate that two molecules of 3 are also involved in the transition state for hydrogen transfer to form B, which is the rate-limiting step. In the presence of ethanol, hydrogen loss from 3 is accelerated and RuD/OH exchange occurs 250 times faster than in its absence. Calculations indicate that the transition state for dihydrogen complex formation involves an ethanol bridge between the acidic CpOH and hydridic RuH of 3; the alcohol facilitates proton transfer and accelerates the reversible formation of dihydrogen complex B. In the presence of EtOH, the rate-limiting step shifts to the loss of hydrogen from B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740149     DOI: 10.1021/ja043460r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Synthesis of Ruthenium Boryl Analogues of the Shvo Metal-Ligand Bifunctional Catalyst.

Authors:  Liza Koren-Selfridge; Ian P Query; Joel A Hanson; Nicholas A Isley; Ilia A Guzei; Timothy B Clark
Journal:  Organometallics       Date:  2010       Impact factor: 3.876

2.  A Three-Stage Mechanistic Model for Ammonia Borane Dehydrogenation by Shvo's Catalyst.

Authors:  Zhiyao Lu; Brian L Conley; Travis J Williams
Journal:  Organometallics       Date:  2012-08-30       Impact factor: 3.876

3.  Trimethylsilyl-Substituted Hydroxycyclopentadienyl Ruthenium Hydrides as Benchmarks to Probe Ligand and Metal Effects on the Reactivity of Shvo Type Complexes.

Authors:  Charles P Casey; Hairong Guan
Journal:  Organometallics       Date:  2011-10-21       Impact factor: 3.876

4.  Tunable, chemoselective amination via silver catalysis.

Authors:  Jared W Rigoli; Cale D Weatherly; Juliet M Alderson; Brian T Vo; Jennifer M Schomaker
Journal:  J Am Chem Soc       Date:  2013-11-11       Impact factor: 15.419

5.  Cyclopentadienone iron alcohol complexes: synthesis, reactivity, and implications for the mechanism of iron-catalyzed hydrogenation of aldehydes.

Authors:  Charles P Casey; Hairong Guan
Journal:  J Am Chem Soc       Date:  2009-02-25       Impact factor: 15.419

6.  Iridium Complex-Catalyzed Transfer Hydrogenation of N-Heteroarenes and Tentative Asymmetric Synthesis.

Authors:  Lu Ouyang; Yanping Xia; Jianhua Liao; Rui Miao; Xiao Yang; Renshi Luo
Journal:  ACS Omega       Date:  2021-04-07

7.  Iridium and Ruthenium Complexes of N-Heterocyclic Carbene- and Pyridinol-Derived Chelates as Catalysts for Aqueous Carbon Dioxide Hydrogenation and Formic Acid Dehydrogenation: The Role of the Alkali Metal.

Authors:  Sopheavy Siek; Dalton B Burks; Deidra L Gerlach; Guangchao Liang; Jamie M Tesh; Courtney R Thompson; Fengrui Qu; Jennifer E Shankwitz; Robert M Vasquez; Nicole Chambers; Gregory J Szulczewski; Douglas B Grotjahn; Charles Edwin Webster; Elizabeth T Papish
Journal:  Organometallics       Date:  2017-03-03       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.